1
Clinical Trials associated with Autologous, Adipose Derived Stromal Vascular Fraction(Antria)A Phase One, Open Label, Single Arm Study to Demonstrate the Safety of Antria Cell Preparation Process During Facial Fat Grafting Assisted With Autologous, Adipose Derived Stromal Vascular Fraction (SVF)
The primary purpose of this study is to demonstrate the safety of injecting the Stromal Vascular Fraction (SVF) [containing Adipose Derived Stem Cells (ADSCs)] enriched fat grafts into regions of the face that require enhancement. The safety of SVF will be evaluated throughout the course of the study phase through the assessment of laboratory values, physical examinations, adverse events, safety phone calls etc.
100 Clinical Results associated with Autologous, Adipose Derived Stromal Vascular Fraction(Antria)
100 Translational Medicine associated with Autologous, Adipose Derived Stromal Vascular Fraction(Antria)
100 Patents (Medical) associated with Autologous, Adipose Derived Stromal Vascular Fraction(Antria)
100 Deals associated with Autologous, Adipose Derived Stromal Vascular Fraction(Antria)